Pharmaceutical reform agreement review report

6 March 2024 - The Department of Health and Aged Care has conducted a review of Pharmaceutical Reform Agreements (PRAs), to ...

Read more →

Biden says Medicare should negotiate prices for at least 50 drugs each year, up from a target of 20

6 March 2024 - That proposal is one of several new health care policy plans Biden will outline during his State ...

Read more →

Early impact of the Inflation Reduction Act on drug discovery

6 March 2024 - Despite the concerns of the biopharma industry, the Inflation Reduction Act has been enacted and with it, ...

Read more →

Drug makers send counter offers for US Medicare price negotiations, Biden says

4 March 2024 - The manufacturers of 10 high cost drugs selected for the US Medicare program's first-ever pricing negotiations ...

Read more →

Federal judge rules against AstraZeneca in lawsuit challenging Medicare drug price negotiation

1 March 2024 - A federal judge in Delaware on Friday ruled against AstraZeneca in a case challenging the constitutionality ...

Read more →

MHRA grants first approval via the new International Recognition Procedure in 30 days

1 March 2024 - Launched in January 2024, IRP aims to further help bring life-saving new medicines to UK patients without ...

Read more →

House looks to weaken Medicare negotiation

29 February 2024 - Two proposals to weaken Medicare’s drug price negotiation program are getting a hearing before a House Energy ...

Read more →

Regulator acts to close loophole enabling Australian pharmacists to make copycat Ozempic drug

29 February 2024 - The TGA will move to ban compounding pharmacists from making their own versions of injectable weight ...

Read more →

Added benefit and revenues of oncology drugs approved by the EMA between 1995 and 2020: retrospective cohort study

28 February 2024 - Added benefit was evaluated using ratings published by seven organisations: health technology assessment agencies from the US, ...

Read more →

Bernie Sanders wants to rein in drug prices. Is he asking the right questions?

28 February 2024 - We have a serious problem of affordability of health care in the US, including the cost of ...

Read more →

The FDA isn’t afraid to yank a disappointing drug

26 February 2024 - The FDA is rescinding its approval of a blood cancer treatment from the Swedish firm Oncopeptides, ...

Read more →

FDA issues final decision to withdraw approval of Pepaxto (melphalan flufenamide)

23 February 2024 - Today, the FDA announced its final decision to withdraw approval of Pepaxto (melphalan flufenamide), which was ...

Read more →

UK's MHRA revokes authorisation for Novartis' sickle cell drug

21 February 2024 - Britain's health regulator said on Wednesday it had revoked a conditional marketing authorisation for Novartis' sickle ...

Read more →

The Biden Administration versus Medicare Advantage

21 February 2024 - When does the failure to answer a phone call in 8 seconds cost the company receiving the ...

Read more →

United Therapeutics starts litigation with FDA over rival Liquidia's drug application

21 February 2024 - United Therapeutics said on Wednesday it had filed a case with the US FDA, alleging that ...

Read more →